nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acetylcholine/riociguat
|
|
|
|
1855 |
1 |
p. 14 |
artikel |
2 |
Aciclovir
|
|
|
|
1855 |
1 |
p. 15 |
artikel |
3 |
Acitretin/nivolumab/prednisone
|
|
|
|
1855 |
1 |
p. 16 |
artikel |
4 |
Adalimumab
|
|
|
|
1855 |
1 |
p. 17 |
artikel |
5 |
Adefovir-dipivoxil/lamivudine
|
|
|
|
1855 |
1 |
p. 18 |
artikel |
6 |
Adenosine/amiodarone
|
|
|
|
1855 |
1 |
p. 20 |
artikel |
7 |
Adenosine/theophylline
|
|
|
|
1855 |
1 |
p. 21 |
artikel |
8 |
Adenosine triphosphate/landiolol/verapamil
|
|
|
|
1855 |
1 |
p. 19 |
artikel |
9 |
Adverse events with DOACs ± aspirin
|
|
|
|
1855 |
1 |
p. 6 |
artikel |
10 |
Afatinib/pembrolizumab
|
|
|
|
1855 |
1 |
p. 22 |
artikel |
11 |
Aflibercept/amlodipine/irbesartan
|
|
|
|
1855 |
1 |
p. 23 |
artikel |
12 |
Aflibercept/brolucizumab
|
|
|
|
1855 |
1 |
p. 24 |
artikel |
13 |
Alcohol/sodium-tetradecyl-sulfate
|
|
|
|
1855 |
1 |
p. 25 |
artikel |
14 |
Alemtuzumab
|
|
|
|
1855 |
1 |
p. 26 |
artikel |
15 |
Alendronic-acid/gonadotropins/hydrocortisone
|
|
|
|
1855 |
1 |
p. 27 |
artikel |
16 |
Alendronic-acid/levetiracetam/omeprazole
|
|
|
|
1855 |
1 |
p. 28 |
artikel |
17 |
Amantadine
|
|
|
|
1855 |
1 |
p. 29 |
artikel |
18 |
Amiodarone/methylprednisolone
|
|
|
|
1855 |
1 |
p. 30 |
artikel |
19 |
Amiodarone/trazodone interaction
|
|
|
|
1855 |
1 |
p. 31 |
artikel |
20 |
Amitriptyline overdose
|
|
|
|
1855 |
1 |
p. 32 |
artikel |
21 |
Amlodipine
|
|
|
|
1855 |
1 |
p. 33 |
artikel |
22 |
Amlodipine/anagrelide
|
|
|
|
1855 |
1 |
p. 34 |
artikel |
23 |
Antibacterials
|
|
|
|
1855 |
1 |
p. 35 |
artikel |
24 |
Anticoagulants
|
|
|
|
1855 |
1 |
p. 36 |
artikel |
25 |
Antiepileptic drugs
|
|
|
|
1855 |
1 |
p. 37 |
artikel |
26 |
Antineoplastic drugs
|
|
|
|
1855 |
1 |
p. 38 |
artikel |
27 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 40 |
artikel |
28 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 39 |
artikel |
29 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 41 |
artikel |
30 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 42 |
artikel |
31 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 43 |
artikel |
32 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 44 |
artikel |
33 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 45 |
artikel |
34 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 46 |
artikel |
35 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 49 |
artikel |
36 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 47 |
artikel |
37 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 48 |
artikel |
38 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 50 |
artikel |
39 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 51 |
artikel |
40 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 52 |
artikel |
41 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 53-54 |
artikel |
42 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 54-55 |
artikel |
43 |
Antineoplastics
|
|
|
|
1855 |
1 |
p. 55 |
artikel |
44 |
Antineoplastics/hydrocortisone
|
|
|
|
1855 |
1 |
p. 56 |
artikel |
45 |
Antiretrovirals
|
|
|
|
1855 |
1 |
p. 57 |
artikel |
46 |
Antiretrovirals
|
|
|
|
1855 |
1 |
p. 58 |
artikel |
47 |
Antivirals
|
|
|
|
1855 |
1 |
p. 59 |
artikel |
48 |
Antivirals/fluoroquinolones
|
|
|
|
1855 |
1 |
p. 60 |
artikel |
49 |
Antivirals/myeloablative-agonists
|
|
|
|
1855 |
1 |
p. 61 |
artikel |
50 |
Anxiety disorders with Janssen's COVID-19 vaccine
|
|
|
|
1855 |
1 |
p. 7 |
artikel |
51 |
Anxiolytics/olanzapine/trazodone
|
|
|
|
1855 |
1 |
p. 62 |
artikel |
52 |
Apixaban
|
|
|
|
1855 |
1 |
p. 63 |
artikel |
53 |
Apixaban
|
|
|
|
1855 |
1 |
p. 64 |
artikel |
54 |
Aspirin/cilostazol/heparin
|
|
|
|
1855 |
1 |
p. 65 |
artikel |
55 |
AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea
|
|
|
|
1855 |
1 |
p. 8 |
artikel |
56 |
AstraZeneca COVID-19 vaccine-related thromboembolism
|
|
|
|
1855 |
1 |
p. 9 |
artikel |
57 |
Atezolizumab: risk of severe cutaneous adverse reactions (SCARs)
|
|
|
|
1855 |
1 |
p. 1 |
artikel |
58 |
Atopic dermatitis following exposure to antibiotics early in life
|
|
|
|
1855 |
1 |
p. 10 |
artikel |
59 |
Atorvastatin
|
|
|
|
1855 |
1 |
p. 66 |
artikel |
60 |
Atorvastatin
|
|
|
|
1855 |
1 |
p. 67 |
artikel |
61 |
Atorvastatin
|
|
|
|
1855 |
1 |
p. 68 |
artikel |
62 |
Atorvastatin/colchicine
|
|
|
|
1855 |
1 |
p. 69 |
artikel |
63 |
Atorvastatin/prednisolone/methylprednisolone
|
|
|
|
1855 |
1 |
p. 70 |
artikel |
64 |
Atropine
|
|
|
|
1855 |
1 |
p. 71 |
artikel |
65 |
Axicabtagene ciloleucel/tisagenlecleucel
|
|
|
|
1855 |
1 |
p. 72 |
artikel |
66 |
Azathioprine/infliximab
|
|
|
|
1855 |
1 |
p. 73 |
artikel |
67 |
Azathioprine/mesalazine
|
|
|
|
1855 |
1 |
p. 74 |
artikel |
68 |
Azathioprine/prednisone
|
|
|
|
1855 |
1 |
p. 75 |
artikel |
69 |
Azathioprine/prednisone withdrawal
|
|
|
|
1855 |
1 |
p. 76 |
artikel |
70 |
Azithromycin
|
|
|
|
1855 |
1 |
p. 77 |
artikel |
71 |
Bendamustine/nivolumab
|
|
|
|
1855 |
1 |
p. 78 |
artikel |
72 |
Benralizumab/mepolizumab/omalizumab
|
|
|
|
1855 |
1 |
p. 79 |
artikel |
73 |
Bentonite/epinephrine
|
|
|
|
1855 |
1 |
p. 80 |
artikel |
74 |
Betamethasone
|
|
|
|
1855 |
1 |
p. 81 |
artikel |
75 |
Betamethasone butyrate propionate/indometacin farnesil
|
|
|
|
1855 |
1 |
p. 82 |
artikel |
76 |
Bicarbonate/epinephrine/glucose
|
|
|
|
1855 |
1 |
p. 83 |
artikel |
77 |
Bleomycin
|
|
|
|
1855 |
1 |
p. 84 |
artikel |
78 |
Bortezomib/cyclophosphamide/dexamethasone
|
|
|
|
1855 |
1 |
p. 85 |
artikel |
79 |
Botulinum antitoxin
|
|
|
|
1855 |
1 |
p. 86 |
artikel |
80 |
Brentuximab vedotin
|
|
|
|
1855 |
1 |
p. 87 |
artikel |
81 |
Brigatinib/carboplatin/lorlatinib
|
|
|
|
1855 |
1 |
p. 88 |
artikel |
82 |
Bupivacaine/butorphanol
|
|
|
|
1855 |
1 |
p. 89 |
artikel |
83 |
Bupivacaine/lidocaine
|
|
|
|
1855 |
1 |
p. 90 |
artikel |
84 |
Buprenorphine/levomepromazine
|
|
|
|
1855 |
1 |
p. 91 |
artikel |
85 |
Caffeine citrate
|
|
|
|
1855 |
1 |
p. 92 |
artikel |
86 |
Canrenoic-acid
|
|
|
|
1855 |
1 |
p. 93 |
artikel |
87 |
Capecitabine/cisplatin
|
|
|
|
1855 |
1 |
p. 94 |
artikel |
88 |
Capecitabine/olaparib
|
|
|
|
1855 |
1 |
p. 95 |
artikel |
89 |
Carbamazepine/zuclopenthixol
|
|
|
|
1855 |
1 |
p. 97 |
artikel |
90 |
Carbimazole
|
|
|
|
1855 |
1 |
p. 98 |
artikel |
91 |
Carboplatin/pembrolizumab/pemetrexed
|
|
|
|
1855 |
1 |
p. 99 |
artikel |
92 |
Carboplatin/sodium-valproate
|
|
|
|
1855 |
1 |
p. 100 |
artikel |
93 |
Carfilzomib/daratumumab/dexamethasone
|
|
|
|
1855 |
1 |
p. 101 |
artikel |
94 |
CAR-T-cell-therapies/cyclophosphamide/fludarabine
|
|
|
|
1855 |
1 |
p. 96 |
artikel |
95 |
Caspofungin
|
|
|
|
1855 |
1 |
p. 102 |
artikel |
96 |
Cefepime
|
|
|
|
1855 |
1 |
p. 103 |
artikel |
97 |
Cefepime
|
|
|
|
1855 |
1 |
p. 104 |
artikel |
98 |
Cefepime
|
|
|
|
1855 |
1 |
p. 105 |
artikel |
99 |
Ceftazidime/vancomycin
|
|
|
|
1855 |
1 |
p. 106 |
artikel |
100 |
Ceftolozane/tazobactam/ganciclovir
|
|
|
|
1855 |
1 |
p. 107 |
artikel |
101 |
Ceftriaxone
|
|
|
|
1855 |
1 |
p. 108 |
artikel |
102 |
Cemiplimab
|
|
|
|
1855 |
1 |
p. 109 |
artikel |
103 |
Chlorambucil/ciclosporin/rituximab
|
|
|
|
1855 |
1 |
p. 110 |
artikel |
104 |
Chloroquine
|
|
|
|
1855 |
1 |
p. 111 |
artikel |
105 |
Ciclosporin
|
|
|
|
1855 |
1 |
p. 112 |
artikel |
106 |
Ciclosporin/mycophenolate-mofetil
|
|
|
|
1855 |
1 |
p. 113 |
artikel |
107 |
Ciclosporin/pednisone
|
|
|
|
1855 |
1 |
p. 114 |
artikel |
108 |
Cisplatin
|
|
|
|
1855 |
1 |
p. 115 |
artikel |
109 |
Cisplatin/fluorouracil
|
|
|
|
1855 |
1 |
p. 116 |
artikel |
110 |
Cisplatin/gemcitabine/pembrolizumab
|
|
|
|
1855 |
1 |
p. 117 |
artikel |
111 |
Cisplatin/pembrolizumab/pemetrexed
|
|
|
|
1855 |
1 |
p. 118 |
artikel |
112 |
Cisplatin/pemetrexed
|
|
|
|
1855 |
1 |
p. 120 |
artikel |
113 |
Cisplatin/pemetrexed
|
|
|
|
1855 |
1 |
p. 119 |
artikel |
114 |
Clindamycin/levofloxacin
|
|
|
|
1855 |
1 |
p. 121 |
artikel |
115 |
Clindamycin/metronidazole/vancomycin
|
|
|
|
1855 |
1 |
p. 122 |
artikel |
116 |
Clobazam/levetiracetam
|
|
|
|
1855 |
1 |
p. 123 |
artikel |
117 |
Clobetasol
|
|
|
|
1855 |
1 |
p. 124 |
artikel |
118 |
Clonazepam
|
|
|
|
1855 |
1 |
p. 125 |
artikel |
119 |
Clopidogrel
|
|
|
|
1855 |
1 |
p. 126 |
artikel |
120 |
Colchicine
|
|
|
|
1855 |
1 |
p. 127 |
artikel |
121 |
COVID-19 vaccination errors in USA reported to ISMP
|
|
|
|
1855 |
1 |
p. 2 |
artikel |
122 |
Crizotinib
|
|
|
|
1855 |
1 |
p. 128 |
artikel |
123 |
Cyclin-dependent kinase inhibitor-related skin reactions
|
|
|
|
1855 |
1 |
p. 11 |
artikel |
124 |
Cyclophosphamide/docetaxel
|
|
|
|
1855 |
1 |
p. 129 |
artikel |
125 |
Cycloserine/ethambutol
|
|
|
|
1855 |
1 |
p. 130 |
artikel |
126 |
Cytarabine/gemtuzumab-ozogamicin
|
|
|
|
1855 |
1 |
p. 131 |
artikel |
127 |
Dabrafenib/trametinib
|
|
|
|
1855 |
1 |
p. 132 |
artikel |
128 |
Dapsone
|
|
|
|
1855 |
1 |
p. 133 |
artikel |
129 |
Dasatinib
|
|
|
|
1855 |
1 |
p. 134 |
artikel |
130 |
Daunorubicin/prednisolone/vincristine
|
|
|
|
1855 |
1 |
p. 135 |
artikel |
131 |
Denosumab
|
|
|
|
1855 |
1 |
p. 136 |
artikel |
132 |
Denosumab/zoledronic-acid
|
|
|
|
1855 |
1 |
p. 137 |
artikel |
133 |
Dexamethasone
|
|
|
|
1855 |
1 |
p. 138 |
artikel |
134 |
Dexamethasone/gemcitabine/oxaliplatin
|
|
|
|
1855 |
1 |
p. 139 |
artikel |
135 |
Dexamethasone/glucocorticoids/pegaspargase
|
|
|
|
1855 |
1 |
p. 140 |
artikel |
136 |
Dexamethasone/lenvatinib interaction
|
|
|
|
1855 |
1 |
p. 141 |
artikel |
137 |
Dexamethasone/remdesivir/warfarin interaction
|
|
|
|
1855 |
1 |
p. 142 |
artikel |
138 |
Diazepam/gabapentin/haloperidol
|
|
|
|
1855 |
1 |
p. 143 |
artikel |
139 |
Dicycloverine
|
|
|
|
1855 |
1 |
p. 144 |
artikel |
140 |
Dimeticone
|
|
|
|
1855 |
1 |
p. 145 |
artikel |
141 |
Duloxetine/tamoxifen
|
|
|
|
1855 |
1 |
p. 146 |
artikel |
142 |
Dupilumab
|
|
|
|
1855 |
1 |
p. 147 |
artikel |
143 |
Durvalumab/tenofovir
|
|
|
|
1855 |
1 |
p. 148 |
artikel |
144 |
Efavirenz/emtricitabine/tenofovir
|
|
|
|
1855 |
1 |
p. 149 |
artikel |
145 |
Eltrombopag
|
|
|
|
1855 |
1 |
p. 151 |
artikel |
146 |
Eltrombopag
|
|
|
|
1855 |
1 |
p. 150 |
artikel |
147 |
Empagliflozin
|
|
|
|
1855 |
1 |
p. 152 |
artikel |
148 |
Epoetin-beta/immunosuppressants
|
|
|
|
1855 |
1 |
p. 153 |
artikel |
149 |
Erenumab
|
|
|
|
1855 |
1 |
p. 154 |
artikel |
150 |
Erlotinib/osimertinib
|
|
|
|
1855 |
1 |
p. 155 |
artikel |
151 |
Esomeprazole
|
|
|
|
1855 |
1 |
p. 156 |
artikel |
152 |
Etoricoxib
|
|
|
|
1855 |
1 |
p. 157 |
artikel |
153 |
FDA approves naloxone 8mg nasal spray for opioid overdose
|
|
|
|
1855 |
1 |
p. 3 |
artikel |
154 |
Fingolimod
|
|
|
|
1855 |
1 |
p. 158 |
artikel |
155 |
Flecainide
|
|
|
|
1855 |
1 |
p. 159 |
artikel |
156 |
Flumazenil/flurazepam/fosphenytoin
|
|
|
|
1855 |
1 |
p. 160 |
artikel |
157 |
Fluorouracil
|
|
|
|
1855 |
1 |
p. 161 |
artikel |
158 |
Fluorouracil/folinic-acid/irinotecan
|
|
|
|
1855 |
1 |
p. 162 |
artikel |
159 |
Fluorouracil/folinic-acid/oxaliplatin
|
|
|
|
1855 |
1 |
p. 163 |
artikel |
160 |
Folic acid
|
|
|
|
1855 |
1 |
p. 164 |
artikel |
161 |
Gemcitabine/paclitaxel
|
|
|
|
1855 |
1 |
p. 165 |
artikel |
162 |
Gentamicin
|
|
|
|
1855 |
1 |
p. 166 |
artikel |
163 |
Glucose/sodium chloride
|
|
|
|
1855 |
1 |
p. 167 |
artikel |
164 |
Heparin
|
|
|
|
1855 |
1 |
p. 170 |
artikel |
165 |
Heparin
|
|
|
|
1855 |
1 |
p. 168 |
artikel |
166 |
Heparin
|
|
|
|
1855 |
1 |
p. 169 |
artikel |
167 |
Hyaluronic acid
|
|
|
|
1855 |
1 |
p. 171 |
artikel |
168 |
Hydrogen peroxide
|
|
|
|
1855 |
1 |
p. 172 |
artikel |
169 |
Hydroxychloroquine/methylprednisolone/nafamostat
|
|
|
|
1855 |
1 |
p. 173 |
artikel |
170 |
Ibrutinib
|
|
|
|
1855 |
1 |
p. 174 |
artikel |
171 |
Icotinib/osimertinib
|
|
|
|
1855 |
1 |
p. 175 |
artikel |
172 |
Imatinib/methotrexate interaction
|
|
|
|
1855 |
1 |
p. 176 |
artikel |
173 |
Imiquimod
|
|
|
|
1855 |
1 |
p. 177 |
artikel |
174 |
Immune-globulin/methylprednisolone
|
|
|
|
1855 |
1 |
p. 178 |
artikel |
175 |
Immune-globulin/plasma/steroids
|
|
|
|
1855 |
1 |
p. 179 |
artikel |
176 |
Immune-globulin/prednisone
|
|
|
|
1855 |
1 |
p. 180 |
artikel |
177 |
Immune-globulin/rituximab
|
|
|
|
1855 |
1 |
p. 181 |
artikel |
178 |
Immunosuppressants
|
|
|
|
1855 |
1 |
p. 183 |
artikel |
179 |
Immunosuppressants
|
|
|
|
1855 |
1 |
p. 184 |
artikel |
180 |
Immunosuppressants
|
|
|
|
1855 |
1 |
p. 182 |
artikel |
181 |
Immunotherapies/temozolomide
|
|
|
|
1855 |
1 |
p. 185 |
artikel |
182 |
Infliximab
|
|
|
|
1855 |
1 |
p. 187 |
artikel |
183 |
Infliximab
|
|
|
|
1855 |
1 |
p. 186 |
artikel |
184 |
Infliximab
|
|
|
|
1855 |
1 |
p. 188 |
artikel |
185 |
Interferon-β-1a
|
|
|
|
1855 |
1 |
p. 189 |
artikel |
186 |
Iodine radioactive/lenvatinib
|
|
|
|
1855 |
1 |
p. 190 |
artikel |
187 |
Iohexol
|
|
|
|
1855 |
1 |
p. 191 |
artikel |
188 |
Iomeprol
|
|
|
|
1855 |
1 |
p. 192 |
artikel |
189 |
Iopromide
|
|
|
|
1855 |
1 |
p. 193 |
artikel |
190 |
Ipilimumab/nivolumab
|
|
|
|
1855 |
1 |
p. 194 |
artikel |
191 |
Ipilimumab/nivolumab/talimogene laherparepvec
|
|
|
|
1855 |
1 |
p. 195 |
artikel |
192 |
Ipilimumab/pembrolizumab
|
|
|
|
1855 |
1 |
p. 196 |
artikel |
193 |
Isoniazid
|
|
|
|
1855 |
1 |
p. 197 |
artikel |
194 |
Ketamine abuse
|
|
|
|
1855 |
1 |
p. 198 |
artikel |
195 |
Letrozole
|
|
|
|
1855 |
1 |
p. 199 |
artikel |
196 |
Letrozole/rasburicase
|
|
|
|
1855 |
1 |
p. 200 |
artikel |
197 |
Levamisole
|
|
|
|
1855 |
1 |
p. 201 |
artikel |
198 |
Levetiracetam
|
|
|
|
1855 |
1 |
p. 202 |
artikel |
199 |
Levetiracetam
|
|
|
|
1855 |
1 |
p. 204 |
artikel |
200 |
Levetiracetam
|
|
|
|
1855 |
1 |
p. 203 |
artikel |
201 |
Levonorgestrel
|
|
|
|
1855 |
1 |
p. 205 |
artikel |
202 |
Link between antidepressant use and youth suicide?
|
|
|
|
1855 |
1 |
p. 4 |
artikel |
203 |
Lithium
|
|
|
|
1855 |
1 |
p. 206 |
artikel |
204 |
Loratadine
|
|
|
|
1855 |
1 |
p. 207 |
artikel |
205 |
Lorazepam
|
|
|
|
1855 |
1 |
p. 208 |
artikel |
206 |
Meglumine-antimonate
|
|
|
|
1855 |
1 |
p. 209 |
artikel |
207 |
Melphalan/mycophenolate-mofetil/nivolumab
|
|
|
|
1855 |
1 |
p. 210 |
artikel |
208 |
Meropenem
|
|
|
|
1855 |
1 |
p. 211 |
artikel |
209 |
Mesalazine
|
|
|
|
1855 |
1 |
p. 212 |
artikel |
210 |
Mesalazine
|
|
|
|
1855 |
1 |
p. 213 |
artikel |
211 |
Methotrexate
|
|
|
|
1855 |
1 |
p. 215 |
artikel |
212 |
Methotrexate
|
|
|
|
1855 |
1 |
p. 214 |
artikel |
213 |
Methotrexate
|
|
|
|
1855 |
1 |
p. 216 |
artikel |
214 |
Methotrexate
|
|
|
|
1855 |
1 |
p. 217 |
artikel |
215 |
Methotrexate
|
|
|
|
1855 |
1 |
p. 218 |
artikel |
216 |
Methotrexate/methylprednisolone/prednisolone
|
|
|
|
1855 |
1 |
p. 219 |
artikel |
217 |
Methotrexate/prednisolone
|
|
|
|
1855 |
1 |
p. 220 |
artikel |
218 |
Methotrexate/prednisolone
|
|
|
|
1855 |
1 |
p. 221 |
artikel |
219 |
Methylprednisolone
|
|
|
|
1855 |
1 |
p. 222 |
artikel |
220 |
Methylprednisolone/prednisolone
|
|
|
|
1855 |
1 |
p. 223 |
artikel |
221 |
Metoprolol/paracetamol/quetiapine
|
|
|
|
1855 |
1 |
p. 224 |
artikel |
222 |
Midazolam
|
|
|
|
1855 |
1 |
p. 225 |
artikel |
223 |
Morphine/oxycodone/naloxone
|
|
|
|
1855 |
1 |
p. 226 |
artikel |
224 |
Multiple drug
|
|
|
|
1855 |
1 |
p. 227 |
artikel |
225 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 234 |
artikel |
226 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 258 |
artikel |
227 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 228 |
artikel |
228 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 243 |
artikel |
229 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 248 |
artikel |
230 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 250 |
artikel |
231 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 251 |
artikel |
232 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 252 |
artikel |
233 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 255 |
artikel |
234 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 237 |
artikel |
235 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 239 |
artikel |
236 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 229 |
artikel |
237 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 230 |
artikel |
238 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 231 |
artikel |
239 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 232 |
artikel |
240 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 233 |
artikel |
241 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 235 |
artikel |
242 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 236-237 |
artikel |
243 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 244 |
artikel |
244 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 245 |
artikel |
245 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 246 |
artikel |
246 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 247 |
artikel |
247 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 249 |
artikel |
248 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 253 |
artikel |
249 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 254 |
artikel |
250 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 256 |
artikel |
251 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 257 |
artikel |
252 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 259 |
artikel |
253 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 238 |
artikel |
254 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 240 |
artikel |
255 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 241 |
artikel |
256 |
Multiple drugs
|
|
|
|
1855 |
1 |
p. 242 |
artikel |
257 |
Multiple drugs abuse
|
|
|
|
1855 |
1 |
p. 260 |
artikel |
258 |
Multiple drugs overdose
|
|
|
|
1855 |
1 |
p. 261 |
artikel |
259 |
Mycophenolate mofetil/prednisone
|
|
|
|
1855 |
1 |
p. 262 |
artikel |
260 |
Mycophenolate mofetil/tacrolimus
|
|
|
|
1855 |
1 |
p. 263 |
artikel |
261 |
Naproxen/paracetamol
|
|
|
|
1855 |
1 |
p. 264 |
artikel |
262 |
Nitrofurantoin
|
|
|
|
1855 |
1 |
p. 265 |
artikel |
263 |
Nivolumab
|
|
|
|
1855 |
1 |
p. 266 |
artikel |
264 |
Nivolumab
|
|
|
|
1855 |
1 |
p. 268 |
artikel |
265 |
Nivolumab
|
|
|
|
1855 |
1 |
p. 269 |
artikel |
266 |
Nivolumab
|
|
|
|
1855 |
1 |
p. 270 |
artikel |
267 |
Nivolumab
|
|
|
|
1855 |
1 |
p. 267 |
artikel |
268 |
Nivolumab/paclitaxel
|
|
|
|
1855 |
1 |
p. 271 |
artikel |
269 |
Nivolumab/pembrolizumab
|
|
|
|
1855 |
1 |
p. 272 |
artikel |
270 |
Non-opioid-analgesics/risedronic-acid/zoledronic-acid
|
|
|
|
1855 |
1 |
p. 273 |
artikel |
271 |
Non-serious case reports
|
|
|
|
1855 |
1 |
p. 317 |
artikel |
272 |
Octreotide
|
|
|
|
1855 |
1 |
p. 274 |
artikel |
273 |
Olanzapine overdose
|
|
|
|
1855 |
1 |
p. 275 |
artikel |
274 |
Olmesartan-medoxomil/spironolactone/torasemide
|
|
|
|
1855 |
1 |
p. 276 |
artikel |
275 |
Opioids/tetrahydrocannabinol
|
|
|
|
1855 |
1 |
p. 277 |
artikel |
276 |
Other adverse reaction research
|
|
|
|
1855 |
1 |
p. 13 |
artikel |
277 |
Oxaliplatin
|
|
|
|
1855 |
1 |
p. 278 |
artikel |
278 |
Oxycodone
|
|
|
|
1855 |
1 |
p. 279 |
artikel |
279 |
Oxycodone
|
|
|
|
1855 |
1 |
p. 280 |
artikel |
280 |
Palbociclib
|
|
|
|
1855 |
1 |
p. 281 |
artikel |
281 |
Pantoprazole
|
|
|
|
1855 |
1 |
p. 282 |
artikel |
282 |
Paracetamol
|
|
|
|
1855 |
1 |
p. 283 |
artikel |
283 |
Paracetamol overdose
|
|
|
|
1855 |
1 |
p. 284 |
artikel |
284 |
Parnaparin sodium/warfarin
|
|
|
|
1855 |
1 |
p. 285 |
artikel |
285 |
Pazopanib
|
|
|
|
1855 |
1 |
p. 286 |
artikel |
286 |
PEG laxatives mixed with starch thickener: risk of aspiration
|
|
|
|
1855 |
1 |
p. 5 |
artikel |
287 |
Pemetrexed/unspecified platinum complexes
|
|
|
|
1855 |
1 |
p. 287 |
artikel |
288 |
Piperacillin/tazobactam/prednisolone
|
|
|
|
1855 |
1 |
p. 288 |
artikel |
289 |
Pneumococcal vaccine
|
|
|
|
1855 |
1 |
p. 289 |
artikel |
290 |
Prednisolone
|
|
|
|
1855 |
1 |
p. 290 |
artikel |
291 |
Prednisolone
|
|
|
|
1855 |
1 |
p. 291 |
artikel |
292 |
Prednisolone/tenofovir
|
|
|
|
1855 |
1 |
p. 292 |
artikel |
293 |
Prednisone/corticosteroids
|
|
|
|
1855 |
1 |
p. 293 |
artikel |
294 |
Propranolol/sotalol
|
|
|
|
1855 |
1 |
p. 294 |
artikel |
295 |
Prothrombin-complex-concentrate
|
|
|
|
1855 |
1 |
p. 295 |
artikel |
296 |
Pyridostigmine
|
|
|
|
1855 |
1 |
p. 296 |
artikel |
297 |
Pyridostigmine
|
|
|
|
1855 |
1 |
p. 297 |
artikel |
298 |
Quetiapine
|
|
|
|
1855 |
1 |
p. 298 |
artikel |
299 |
Ranibizumab
|
|
|
|
1855 |
1 |
p. 299 |
artikel |
300 |
Rivoceranib
|
|
|
|
1855 |
1 |
p. 300 |
artikel |
301 |
Roxadustat
|
|
|
|
1855 |
1 |
p. 301 |
artikel |
302 |
Sulfasalazine
|
|
|
|
1855 |
1 |
p. 302 |
artikel |
303 |
Sunitinib
|
|
|
|
1855 |
1 |
p. 303 |
artikel |
304 |
Tacrolimus
|
|
|
|
1855 |
1 |
p. 304 |
artikel |
305 |
Tenecteplase
|
|
|
|
1855 |
1 |
p. 305 |
artikel |
306 |
Terbinafine
|
|
|
|
1855 |
1 |
p. 306 |
artikel |
307 |
Teriparatide
|
|
|
|
1855 |
1 |
p. 307 |
artikel |
308 |
Tetrabenazine/tramadol interaction
|
|
|
|
1855 |
1 |
p. 308 |
artikel |
309 |
Thiamazole
|
|
|
|
1855 |
1 |
p. 309 |
artikel |
310 |
Trimetazidine
|
|
|
|
1855 |
1 |
p. 310 |
artikel |
311 |
TTS with Janssen's COVID-19 vaccine
|
|
|
|
1855 |
1 |
p. 12 |
artikel |
312 |
Vancomycin/voriconazole
|
|
|
|
1855 |
1 |
p. 311 |
artikel |
313 |
Venetoclax
|
|
|
|
1855 |
1 |
p. 312 |
artikel |
314 |
Venetoclax/DNA methylation inhibitors
|
|
|
|
1855 |
1 |
p. 313 |
artikel |
315 |
Vincristine
|
|
|
|
1855 |
1 |
p. 314 |
artikel |
316 |
Warfarin
|
|
|
|
1855 |
1 |
p. 315 |
artikel |
317 |
Zolpidem abuse
|
|
|
|
1855 |
1 |
p. 316 |
artikel |